glutoxim

01/01/2002 - "Results of the randomized study at the patients with severe disseminated drug-sensitive and drug-resistant pulmonary tuberculosis demonstrated high efficacy of the glutoxim and its good tolerability. "
01/01/2007 - "Glutoxim treatment was performed in 73 patients with pulmonary tuberculosis (a study group). "
01/01/2007 - "[Glutoxim in the surgical treatment of patients with pulmonary tuberculosis]."
01/01/2003 - "The paper deals with the effect of glutoxim included into a preoperative preparation regimen on immunological parameters in patients with fibrocavernous pulmonary tuberculosis. "
01/01/2007 - "Twenty-nine patients with pulmonary tuberculosis received glutoxim therapy (a study group). "

01/01/2006 - "The results of studies of ocular tuberculosis in children, as well as the efficacy of the new Russian immunotropic drugs glutoxim and betaleukin are outlined."

01/01/2007 - "To improve the results of treatment in patients with tuberculosis in the intensive phase, the authors used glutoxim, a representative of thiopoeitins. "
01/01/2003 - "Indications for the use of glutoxim in the treatment of tuberculosis are specified on the basis of the baseline immunological parameters of each patient."
01/01/2002 - "[Glutoxim in the complex treatment of tuberculosis]."
01/01/2002 - "Glutoxim application was specially favorable at the patients with severe tuberculosis complicated by viral or medicamental hepatitis."
01/01/2002 - "Glutoxim administration allowed to shorten the period of tuberculosis intoxication signs disappearance, to shorten the period of sputum negativation and shortened the period of pulmonary inflammation reverse process. "

01/01/2002 - "Glutoxim administration allowed to shorten the period of tuberculosis intoxication signs disappearance, to shorten the period of sputum negativation and shortened the period of pulmonary inflammation reverse process. "
01/01/2007 - "A course of glutoxim therapy was 35 days; the daily dose was 60 mg. Postoperative complications (tuberculous pleural empyema with bronchopleural fistula, progressive tuberculosis, nonspecific pneumonias) developed in 2 (6.9%) study group patients and in 8 (32%) control ones (p < 0.05). "

01/01/2007 - "A course of glutoxim therapy was 35 days; the daily dose was 60 mg. Postoperative complications (tuberculous pleural empyema with bronchopleural fistula, progressive tuberculosis, nonspecific pneumonias) developed in 2 (6.9%) study group patients and in 8 (32%) control ones (p < 0.05). "